NCT00004938已完成2 期
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
OBJECTIVE:
I. Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral sporotrichosis.
详细描述
PROTOCOL OUTLINE:
Patients are treated with daily oral fluconazole for up to 24 months. Follow-up continues for at least 1 year.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •-Disease Characteristics-- Presumptive evidence of sporotrichosis Culture-proven sporotrichosis determined on study Relapsing disease following antifungal therapy eligible if culture positive for Sporothrix schenckii prior to entry No life-threatening disease No central nervous system sporotrichosis --Prior/Concurrent Therapy-- No concurrent drugs known to react with fluconazole No more than 3 days of systemic antifungals for current sporotrichosis episode --Patient Characteristics-- Hepatic: Liver function tests no greater than 5 times normal Other: No HIV infection No pregnant or nursing women
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency SyndromeHistoplasmosisHIV InfectionsNCT00000627National Institute of Allergy and Infectious Diseases (NIAID)90
已完成
2 期
Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and SporotrichosisHistoplasmosisBlastomycosisSporotrichosisNCT00004808National Center for Research Resources (NCRR)78
已完成
不适用
Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal MeningitisHIV InfectionsMeningitisNCT00002010Pfizer
已完成
不适用
A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.Meningitis, CryptococcalHIV InfectionsNCT00002113Pfizer64
已完成
3 期
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCandidiasis, EsophagealHIV InfectionsNCT00002339Pfizer100